Aducanumab and Accelerated Approval: Where Do We Go From Here?

HOME/Commentary & Opinion/Aducanumab and Accelerated Approval: Where Do We Go From Here?

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115

About PORTAL
Our Team
Our Work
Careers
Contact

Privacy Policy
Terms of Use
Cookie Policy
Consent Preferences